Endovascular therapy of acute ischemic stroke: Report of the Standards of Practice Committee of the Society of NeuroInterventional Surgery

Journal of NeuroInterventional Surgery

Volumn 4, Issue 2, 2012, Pages 87-93

  Blackham, K A ^a   Meyers, P M ^b,c   Abruzzo, T A ^d   Alberquerque, F C ^e   Fiorella, D ^f   Fraser, J ^g   Frei, D ^h   Gandhi, C D ⁱ   Heck, D V ^j   Hirsch, J A ^k   Hsu, D P ^a   Jayaraman, M ^l,m   Narayanan, S ⁿ   Prestigiacomo, C ^o   Sunshine, J L ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

^c NEUROLOGICAL INSTITUTE   (United States)

^d UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^e Barrow Neurosurgical Associates Ltd   (United States)

^f STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^g UNIVERSITY OF KENTUCKY   (United States)

^h Radiology Imaging Associates   (United States)

ⁱ New Jersey Medical School   (United States)

^j Department of Radiology   (United States)

^k MASSACHUSETTS GENERAL HOSPITAL   (United States)

^l BROWN UNIVERSITY   (United States)

^m RHODE ISLAND HOSPITAL   (United States)

ⁿ WAYNE STATE UNIVERSITY   (United States)

^o UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ALTEPLASE; DESMOTEPLASE; HEPARIN; OCRIPLASMIN; PLACEBO; PLASMIN; PROUROKINASE; RETEPLASE; SARUPLASE; TENECTEPLASE;

ADJUVANT THERAPY; ARTERY OCCLUSION; ASPIRATION CATHETER; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COMBINATION CHEMOTHERAPY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; ENDOVASCULAR THERAPY; HUMAN; IN-STENT RESTENOSIS; INTRACRANIAL STENTING; LOW DRUG DOSE; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROIMAGING; NEUROLOGICAL AND SENSORIAL PROCEDURES; OFF LABEL DRUG USE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT CARE; POSTERIOR CIRCULATION OCCLUSION; PRIORITY JOURNAL; REVIEW; STENT; STROKE; THROMBUS ASPIRATION;

AMERICAN HEART ASSOCIATION; BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; COMBINED MODALITY THERAPY; ENDOVASCULAR PROCEDURES; FIBRINOLYTIC AGENTS; HUMANS; PRACTICE GUIDELINES AS TOPIC; RESEARCH REPORT; SOCIETIES, MEDICAL; STROKE; THROMBOLYTIC THERAPY; UNITED STATES;

EID: 84857421709     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/neurintsurg-2011-010243     Document Type: Review

References (83)

1. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 2007;115: e478-534.
2. Meyers PM, Schumacher HC, Higashida RT, et al. Indications for the performance of intracranial endovascular neurointerventional procedures: a scientific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation 2009;119: 2235-49.
3. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statisticsd2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119:e21-181.
4. Sacco RL, Benjamin EJ, Broderick JP, et al. American Heart Association Prevention Conference. IV. Prevention and rehabilitation of stroke. Risk factors. Stroke 1997;28:1507-17.
5. Adelman SM. The National Survey of Stroke. Economic impact. Stroke 1981;12 (Suppl 1):I69-87.
6. Taylor TN, Davis PH, Torner JC, et al. Lifetime cost of stroke in the United States. Stroke 1996;27:1459-66. (Pubitemid 26295889)
7. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:e69-171.
8. Cloft HJ, Rabinstein A, Lanzino G, et al. Intra-arterial stroke therapy: an assessment of demand and available work force. AJNR Am J Neuroradiol 2009;30:453-8.
9. Hirsch JA, Yoo AJ, Nogueira RG, et al. Case volumes of intra-arterial and intravenous treatment of ischemic stroke in the USA. J Neurointerv Surg 2009;1:27-31.
10. Meyers PM, Schumacher HC, Alexander MJ, et al. Performance and training standards for endovascular ischemic stroke treatment. J Neurointerv Surg 2009;1:10-12.
11. Standard for the Performance of Diagnostic Cervicocerebral Angiography in Adults, in ACR Practice Guidelines. Reston, VA: American College of Radiology, 2006: 71-85.
12. Gomez C, Kinkel P, Masdeu J, et al. American Academy of Neurology guidelines for credentialing in neuroimaging. Report from the task force on updating guidelines for credentialing in neuroimaging. Neurology 1997;49:1734-7. (Pubitemid 28015154)
13. Anon. Quality improvement guidelines for adult diagnostic neuroangiography. Cooperative study between the ASNR, ASITN, and the SCVIR. AJNR Am J Neuroradiol 2000;21:146-50.
14. Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1986;89(2 Suppl):2Se3S.
15. Gibbons RJ, Smith SC Jr, Antman E; American College of Cardiology; American Heart Association. American College of Cardiology/American Heart Association clinical practice guidelines: Part II: evolutionary changes in a continuous quality improvement project. Circulation 2003;107:3101-7. (Pubitemid 36763546)
16. Gibbons RJ, Smith S, Antman E; American College of Cardiology; American Heart Association. American College of Cardiology/American Heart Association clinical practice guidelines: Part I: where do they come from? Circulation 2003;107:2979-86. (Pubitemid 36736643)
17. OCEBM Levels of Evidence Working Group. The Oxford 2011 Levels of Evidence. Oxford Centre for Evidence-Based Medicine. http://www.cebm.net/index. aspx?o=5653 (accessed 1 Sep 2011).
18. del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998;29:4-11. (Pubitemid 28046933)
19. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-11.
20. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432-8. (Pubitemid 40967507)
21. Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761-8.
22. Saqqur M, Uchino K, Demchuk AM, et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007;38:948-54. (Pubitemid 46568457)
23. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29.
24. Wahlgren N, Ahmed N, Eriksson N, et al. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke- MOnitoring STudy (SITS-MOST). Stroke 2008;39:3316-22.
25. Anon. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-7.
26. Del Zoppo GJ, Saver JL, Jauch EC, et al. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009;40:2945-8.
27. Albers GW, Amarenco P, Easton JD, et al. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):483S-512S. (Pubitemid 39297962)
28. Wahlgren N, Ahmed N, Dávalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007;369:275-82. (Pubitemid 46138121)
29. Riedel CH, Zimmermann P, Jensen-Kondering U, et al. The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke 2011;42:1775-7.
30. Alberts MJ, Latchaw RE, Selman WR, et al. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke 2005;36:1597-616. (Pubitemid 40973803)
31. Schwamm LH, Pancioli A, Acker JE 3rd, et al. Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Stroke 2005;36:690-703. (Pubitemid 40344183)
32. George MG, Tong X, McGruder H, et al. Paul Coverdell National Acute Stroke Registry Surveillance - four states, 2005-2007. MMWR Surveill Summ 2009;58:1-23.
33. Schwamm LH, Fonarow GC, Reeves MJ, et al. Get with the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation 2009;119:107-15.
34. Alberts MJ, Latchaw RE, Jagoda A, et al. Revised and updated recommendations for the establishment of primary stroke centers: a summary statement from the brain attack coalition. Stroke 2011;42:2651-65.
35. Nogueira RG, Schwamm LH, Hirsch JA, et al. Endovascular approaches to acute stroke, part 1: Drugs, devices, and data. AJNR Am J Neuroradiol 2009;30:649-61.
36. Lee M, Hong KS, Saver JL, et al. Efficacy of intra-arterial fibrinolysis for acute ischemic stroke: meta-analysis of randomized controlled trials. Stroke 2010;41:932-7.
37. Lisboa RC, Jovanovic BD, Alberts MJ, et al. Analysis of the safety and efficacy of intra-arterial thrombolytic therapy in ischemic stroke. Stroke 2002;33:2866-71. (Pubitemid 35462858)
38. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a metaanalysis. Stroke 2007;38:967-73. (Pubitemid 46568460)
39. Bourekas EC, Slivka AP, Shah R, et al. Intraarterial thrombolytic therapy within 3 hours of the onset of stroke. Neurosurgery 2004;54:39-44.
40. Moazami N, Smedira NG, McCarthy PM, et al. Safety and efficacy of intraarterial thrombolysis for perioperative stroke after cardiac operation. Ann Thorac Surg 2001;72:1933-7.
41. Mathews MS, Sharma J, Snyder KV, et al. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset. Neurosurgery 2009;65:860-5.
42. Lewandowski CA, Frankel M, Tomsick TA, et al. Combined intravenous and intraarterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999;30:2598-605.
43. IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004;35:904-11.
44. IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II Study. Stroke 2007;38:2127-35.
45. Wolfe T, Suarez JI, Tarr RW, et al. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke. J Stroke Cerebrovasc Dis 2008;17:121-8. (Pubitemid 351626608)
46. Zaidat OO, Suarez JI, Santillan C, et al. Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion. Stroke 2002;33:1821-6. (Pubitemid 34761068)
47. Han MK, Kim SH, Ko SB, et al. Combined intravenous and intraarterial revascularization therapy using MRI perfusion/diffusion mismatch selection for acute ischemic stroke at 3-6 h after symptom onset. Neurocrit Care 2008;8:353-9.
48. Georgiadis AL, Memon MZ, Shah QA, et al. Comparison of partial (.6 mg/kg) versus full-dose (.9 mg/kg) intravenous recombinant tissue plasminogen activator followed by endovascular treatment for acute ischemic stroke: a meta-analysis. J Neuroimaging 2011;21:113-20.
49. Food and Drug Administration. Final Decision 510(k) for Concentric Merci(R) Retriever, August 11, 2004. http://www.fda.gov/cdrh/pdf3/k033736.pdf (accessed 1 Feb 2005).
50. Becker KJ, Brott TG. Approval of the MERCI clot retriever: a critical view. Stroke 2005;36:400-3. (Pubitemid 40170829)
51. Nogueira RG, Liebeskind DS, Sung G, et al. Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials. Stroke 2009;40:3777-83.
52. Kelly ME, Furlan AJ, Fiorella D. Recanalization of an acute middle cerebral artery occlusion using a self-expanding, reconstrainable, intracranial microstent as a temporary endovascular bypass. Stroke 2008;39:1770-3.
53. Levy EI, Mehta R, Gupta R, et al. Self-expanding stents for recanalization of acute cerebrovascular occlusions. AJNR Am J Neuroradiol 2007;28:816-22. (Pubitemid 46776054)
54. Lum C, Stys PK, Hogan MJ, et al. Acute anterior circulation stroke: recanalization using clot angioplasty. Can J Neurol Sci 2006;33:217-22. (Pubitemid 43845178)
55. Nogueira RG, Schwamm LH, Buonanno FS, et al. Low-pressure balloon angioplasty with adjuvant pharmacological therapy in patients with acute ischemic stroke caused by intracranial arterial occlusions. Neuroradiology 2008;50:331-40.
56. Fiorella DJ, Levy EI, Turk AS, et al. Target lesion revascularization after wingspan: assessment of safety and durability. Stroke 2009;40:106-10.
57. Levy EI, Siddiqui AH, Crumlish A, et al. First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke). Stroke 2009;40:3552-6.
58. Miteff F, Faulder KC, Goh AC, et al. Mechanical thrombectomy with a self-expanding retrievable intracranial stent (Solitaire AB): experience in 26 patients with acute cerebral artery occlusion. AJNR Am J Neuroradiol 2011;32:1078-81.
59. Lindsberg PJ, Mattle HP. Therapy of basilar artery occlusion: a systematic analysis comparing intra-arterial and intravenous thrombolysis. Stroke 2006;37:922-8. (Pubitemid 43731936)
60. Hacke W, Zeumer H, Ferbert A, et al. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988;19:1216-22.
61. Levy EI, Firlik AD, Wisniewski S, et al. Factors affecting survival rates for acute vertebrobasilar artery occlusions treated with intra-arterial thrombolytic therapy: a meta-analytical approach. Neurosurgery 1999;45:539-45.
62. Smith WS. Intra-arterial thrombolytic therapy for acute basilar occlusion: pro. Stroke 2007;38(2 Suppl):701-3. (Pubitemid 46188250)
63. Schonewille WJ, Wijman CA, Michel P, et al. Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol 2009;8:724-30.
64. Nogueira RG, Yoo AJ, Buonanno FS, et al. Endovascular approaches to acute stroke, part 2: a comprehensive review of studies and trials. AJNR Am J Neuroradiol 2009;30:859-75.
65. Nahab F, Walker GA, Dion JE, et al. Safety of periprocedural heparin in acute ischemic stroke endovascular therapy: The multi MERCI trial. J Stroke Cerebrovasc Dis. Published Online First: 1 June 2011. doi:10.1016/j. jstrokecerebrovasdis.2011.04.009.
66. Anon. Abciximab in acute ischemic stroke: a randomized, double-blind, placebocontrolled, dose-escalation study. The Abciximab in Ischemic Stroke Investigators. Stroke 2000;31:601-9.
67. Adams HP Jr, Effron MB, Torner J, et al. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke 2008;39:87-99.
68. Molina CA, Saver JL. Extending reperfusion therapy for acute ischemic stroke: emerging pharmacological, mechanical, and imaging strategies. Stroke 2005;36:2311-20. (Pubitemid 41429268)
69. Qureshi AI, Ali Z, Suri MF, et al. Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke. Neurosurgery 2001;49:41-8.
70. Haley EC Jr, Thompson JL, Grotta JC, et al. Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial. Stroke 2010;41:707-11.
71. Hacke W, Furlan AJ, Al-Rawi Y, et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009;8:141-50.
72. von Kummer R. Early major ischemic changes on computed tomography should preclude use of tissue plasminogen activator. Stroke 2003;34:820-1.
73. Barber PA, Demchuk AM, Zhang J, et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 2000;355:1670-4. (Pubitemid 30248478)
74. Sunshine JL, Tarr RW, Lanzieri CF, et al. Hyperacute stroke: ultrafast MR imaging to triage patients prior to therapy. Radiology 1999;212:325-32. (Pubitemid 29356548)
75. Wintermark M, Reichhart M, Cuisenaire O, et al. Comparison of admission perfusion computed tomography and qualitative diffusion- and perfusion-weighted magnetic resonance imaging in acute stroke patients. Stroke 2002; 33:2025-31. (Pubitemid 34840062)
76. Heidenreich JO, Hsu D, Wang G, et al. Magnetic resonance imaging results can affect therapy decisions in hyperacute stroke care. Acta Radiol 2008;49:550-7.
77. Leifer D, Bravata DM, Connors JJ 3rd, et al. Metrics for measuring quality of care in comprehensive stroke centers: detailed follow-up to Brain Attack Coalition comprehensive stroke center recommendations: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:849-77.
78. Albers GW, Thijs VN, Wechsler L, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006;60:508-17. (Pubitemid 44871793)
79. Schellinger PD, Bryan RN, Caplan LR, et al. Evidence-based guideline: The role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2010;75:177-85.
80. Yoo AJ, Verduzco LA, Schaefer PW, et al. MRI-based selection for intra-arterial stroke therapy: value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization. Stroke 2009;40:2046-54.
81. Jovin TG, Yonas H, Gebel JM, et al. The cortical ischemic core and not the consistently present penumbra is a determinant of clinical outcome in acute middle cerebral artery occlusion. Stroke 2003;34:2426-33. (Pubitemid 37221955)
82. Thomalla GJ, Kucinski T, Schoder V, et al. Prediction of malignant middle cerebral artery infarction by early perfusion- and diffusion-weighted magnetic resonance imaging. Stroke 2003;34:1892-9. (Pubitemid 36944776)
83. Mlynash M, Lansberg MG, De Silva DA, et al. Refining the definition of the malignant profile: insights from the DEFUSE-EPITHET pooled data set. Stroke 2011;42:1270-5.